References
- Perez E, Bania TC, Medlej K, et al. Determining the optimal dose of intravenous fat emulsion for the treatment of severe verapamil toxicity in a rodent model. Acad Emerg Med. 2008;15:1284–1289.
- American College of Medical Toxicology. ACMT Position Statement: guidance for the use of intravenous lipid emulsion. J Med Toxicol. 2017;13:124–125.
- Lavonas EJ, Drennan IR, Gabrielli A, et al. Part 10: special circumstances of resuscitation: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132:S501–S518.
- Neal JM, Mulroy MF, Weinberg GL, et al. American Society of Regional Anesthesia and Pain Medicine checklist for managing local anesthetic systemic toxicity: 2012 version. Reg Anesth Pain Med. 2012;37:16–18.
- Gosselin S, Hoegberg LC, Hoffman RS, et al. Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol. 2016;54:899–923.
- Fettiplace MR, Akpa BS, Rubinstein I, et al. Confusion about infusion: rational volume limits for intravenous lipid emulsion during treatment of oral overdoses. Ann Emerg Med. 2015;66:185–188.
- Jeong J. Continuous renal replacement therapy circuit failure after antidote administration. Clin Toxicol. 2014;52:1296–1297.
- Rodriguez B, Wilhelm A, Kokko KE. Lipid emulsion use precluding renal replacement therapy. J Emerg Med. 2014;47:635–637.
- Lee HM, Archer JR, Dargan PI, et al. What are the adverse effects associated with the combined use of intravenous lipid emulsion and extracorporeal membrane oxygenation in the poisoned patient? Clin Toxicol. 2015;53:145–150.
- Albrecht E, Baeriswyl M, Orrit J, et al. Lipid emulsion layering in extracorporeal membrane oxygenation circuit. Intensive Care Med. 2016;42:1806–1807.